There's one big difference though - Pfizer is seeking a green light for second booster dose of Comirnaty for people aged 60 and over and those in high-risk groups, while Moderna is going for a ...

Ward said it would be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking about the population at risk ...

How are the new vaccines different from last fall’s boosters? The updated mRNA vaccines from Moderna and Pfizer-BioNTech ...

The Cambridge-based company’s latest COVID shot was approved three weeks earlier than last year, according to a statement ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory ...

Who's eligible for a booster? If you got Pfizer or Moderna, you're eligible for a booster if you're 65 years of age or older. If you're age 18 or older and you live in a long-term care setting.

Yes, older Americans should get yet another COVID shot—but if you have already gotten the latest version, there's no rush.

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

many people are passing on the annual booster shots. With this in mind, is the luster of mRNA companies like BioNTech and Moderna gone? Are they one-trick ponies who found tremendous success only ...

Coegi used more than 500 million impressions and paid social optimized with attention and emotion metrics to drive 24% of ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...